Evaluating the Efficacy of NTI164 in Young People With Autism Spectrum Disorder
Status:
Not yet recruiting
Trial end date:
2023-11-30
Target enrollment:
Participant gender:
Summary
This is an 18 to 54 week study assessing the efficacy of Full-Spectrum Medicinal Cannabis
Plant Extract 0.08% THC (NTI164) on the severity of autism spectrum disorder in young people.